286 related articles for article (PubMed ID: 21810482)
1. Structure-based drug design to augment hit discovery.
Kalyaanamoorthy S; Chen YP
Drug Discov Today; 2011 Sep; 16(17-18):831-9. PubMed ID: 21810482
[TBL] [Abstract][Full Text] [Related]
2. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of anti-infectives.
Agarwal AK; Fishwick CW
Ann N Y Acad Sci; 2010 Dec; 1213():20-45. PubMed ID: 21175675
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in computer-aided drug design.
Song CM; Lim SJ; Tong JC
Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
[TBL] [Abstract][Full Text] [Related]
5. Computer-aided drug discovery and development.
Zhang S
Methods Mol Biol; 2011; 716():23-38. PubMed ID: 21318898
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Docking and scoring in virtual screening for drug discovery: methods and applications.
Kitchen DB; Decornez H; Furr JR; Bajorath J
Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
[TBL] [Abstract][Full Text] [Related]
8. Structure-based drug metabolism predictions for drug design.
Sun H; Scott DO
Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193
[TBL] [Abstract][Full Text] [Related]
9. Hit discovery and hit-to-lead approaches.
Keseru GM; Makara GM
Drug Discov Today; 2006 Aug; 11(15-16):741-8. PubMed ID: 16846802
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the use of open-source software applications in drug discovery.
Geldenhuys WJ; Gaasch KE; Watson M; Allen DD; Van der Schyf CJ
Drug Discov Today; 2006 Feb; 11(3-4):127-32. PubMed ID: 16533710
[TBL] [Abstract][Full Text] [Related]
11. [An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery].
Hirono S
Rinsho Byori; 2002 Jan; 50(1):45-51. PubMed ID: 11871136
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics platform development: from gene to lead compound.
Ivanov AS; Veselovsky AV; Dubanov AV; Skvortsov VS
Methods Mol Biol; 2006; 316():389-431. PubMed ID: 16671411
[TBL] [Abstract][Full Text] [Related]
13. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
Cohen C; Fischel O; Cohen E
Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
[TBL] [Abstract][Full Text] [Related]
14. Prioritizing hits from phenotypic high-content screens.
Low J; Stancato L; Lee J; Sutherland JJ
Curr Opin Drug Discov Devel; 2008 May; 11(3):338-45. PubMed ID: 18428087
[TBL] [Abstract][Full Text] [Related]
15. In silico pharmacology for a multidisciplinary drug discovery process.
Ortega SS; Cara LC; Salvador MK
Drug Metabol Drug Interact; 2012; 27(4):199-207. PubMed ID: 23152402
[TBL] [Abstract][Full Text] [Related]
16. Hit finding: towards 'smarter' approaches.
Langer T; Hoffmann R; Bryant S; Lesur B
Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
[TBL] [Abstract][Full Text] [Related]
17. Structure-based approaches to antibiotic drug discovery.
Nicola G; Abagyan R
Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
[TBL] [Abstract][Full Text] [Related]
18. Free resources to assist structure-based virtual ligand screening experiments.
Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening in lead discovery and optimization.
Jain AN
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]